Abpro Holdings Inc. (NASDAQ:ABP – Get Free Report) was the target of a significant growth in short interest in the month of September. As of September 30th, there was short interest totaling 3,190,000 shares, a growth of 68.8% from the September 15th total of 1,890,000 shares. Approximately 9.2% of the company’s stock are short sold. Based on an average daily volume of 10,040,000 shares, the days-to-cover ratio is currently 0.3 days. Based on an average daily volume of 10,040,000 shares, the days-to-cover ratio is currently 0.3 days. Approximately 9.2% of the company’s stock are short sold.
Institutional Investors Weigh In On Abpro
A hedge fund recently bought a new stake in Abpro stock. Goldman Sachs Group Inc. bought a new position in shares of Abpro Holdings Inc. (NASDAQ:ABP – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 72,106 shares of the company’s stock, valued at approximately $30,000. Goldman Sachs Group Inc. owned 0.14% of Abpro at the end of the most recent reporting period. 23.30% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
ABP has been the topic of a number of recent research reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Abpro in a research note on Wednesday, October 8th. Maxim Group lowered shares of Abpro from a “buy” rating to a “hold” rating in a research report on Tuesday. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Reduce” and a consensus target price of $4.00.
Abpro Trading Up 3.2%
Shares of Abpro stock opened at $0.21 on Thursday. Abpro has a 1 year low of $0.15 and a 1 year high of $13.00. The company has a 50 day simple moving average of $0.22 and a two-hundred day simple moving average of $0.23.
Abpro (NASDAQ:ABP – Get Free Report) last announced its quarterly earnings data on Wednesday, August 13th. The company reported ($0.04) earnings per share for the quarter.
Abpro Company Profile
Abpro Holdings Inc is a biotechnology company. The company’s mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc, formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.
Featured Articles
- Five stocks we like better than Abpro
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Archer’s Recent String of Victories Signals a New Phase of Growth
- What Are the FAANG Stocks and Are They Good Investments?
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- How to Short Nasdaq: An Easy-to-Follow Guide
- The Best AI for Picking Stocks, Ranked by Performance
Receive News & Ratings for Abpro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abpro and related companies with MarketBeat.com's FREE daily email newsletter.